|
FY2023
12 months to Sep 30, 2023
|
FY2022
12 months to Sep 30, 2022
|
FY2021
12 months to Sep 30, 2021
|
FY2020
12 months to Sep 30, 2020
|
FY2019
12 months to Sep 30, 2019
|
|
|---|---|---|---|---|---|
| Operating activities: | |||||
| Consolidated net (loss) income | |||||
| Adjustments to reconcile consolidated net (loss) income to net cash provided by operating activities: | |||||
| Depreciation, depletion and amortization | |||||
| Deferred income tax benefit | |||||
| Share-based compensation expense | |||||
| 401(k) match and company contribution in common stock | |||||
| Pension and other postretirement funding (more) less than cost (income) | |||||
| Multiemployer pension withdrawal (income) expense | |||||
| Cash surrender value increase in excess of premiums paid | |||||
| Equity in income of unconsolidated entities | |||||
| Gain on sale of sawmill | |||||
| Gain on sale of RTS and Chattanoonga | |||||
| Gain on sale of other businesses | |||||
| Gain on sale of investment | |||||
| Goodwill impairment | |||||
| Mineral rights impairment | |||||
| Impairment of goodwill and mineral rights | |||||
| Other impairment adjustments | |||||
| (Gain) loss on disposal of plant, equipment and other, net | |||||
| Other | |||||
| Change in operating assets and liabilities, net of acquisitions and divestitures: | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Other assets | |||||
| Accounts payable | |||||
| Income taxes | |||||
| Accrued liabilities and other | |||||
| Net cash provided by operating activities | |||||
| Investing activities: | |||||
| Capital expenditures | |||||
| Cash paid for purchase of businesses, net of cash acquired | |||||
| Proceeds from corporate owned life insurance | |||||
| Proceeds from sale of sawmill | |||||
| Proceeds from sale of RTS and Chattanooga, net | |||||
| Proceeds from sale of other businesses | |||||
| Proceeds from currency forward contracts | |||||
| Proceeds from the sale of unconsolidated entities | |||||
| Proceeds from sale of investment | |||||
| Proceeds from sale of property, plant and equipment | |||||
| Proceeds from property, plant and equipment insurance settlement | |||||
| Other | |||||
| Net cash used for investing activities | |||||
| Financing activities: | |||||
| Additions to revolving credit facilities | |||||
| Repayments of revolving credit facilities | |||||
| Additions to debt | |||||
| Repayments of debt | |||||
| Changes in commercial paper, net | |||||
| Other debt (repayments) additions, net | |||||
| Issuances of common stock, net of related tax withholdings | |||||
| Purchases of common stock | |||||
| Cash dividends paid to stockholders | |||||
| Other | |||||
| Net cash used for financing activities | |||||
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | |||||
| Increase (Decrease) in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at beginning of period | |||||
| Cash, cash equivalents and restricted cash at end of period | |||||
| Income taxes, net of refunds | |||||
| Interest, net of amounts capitalized | |||||
Loading...